These results suggest the possibility that the accumulation of SIAH2 could be inversely correlated with the expression of key proteins that control tumor progression and invasion, like DYRK2 or STAT3, pointing out SIAH2 as a potential therapeutic target. The gene discussed is SIAH2; the disease is neoplasm.